Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 102

Similar articles for PubMed (Select 22156903)

1.

High-intensity focused ultrasound as an alternative to the surgical approach in primary hyperparathyroidism: a preliminary experience.

Ambrosini CE, Cianferotti L, Picone A, Torregrossa L, Segnini G, Frustaci G, Cetani F, Basolo F, Marcocci C, Miccoli P.

J Endocrinol Invest. 2011 Oct;34(9):655-9.

PMID:
22156903
2.
3.

High-intensity focused ultrasound ablation: an effective and safe treatment for secondary hypersplenism.

Zhu J, Zhu H, Mei Z, Zhang L, Jin C, Ran L, Zhou K, Yang W.

Br J Radiol. 2014 Nov;87(1043):20140374. doi: 10.1259/bjr.20140374. Epub 2014 Aug 20.

PMID:
25141274
4.

Surgical management of primary hyperparathyroidism in older adults.

Denizot A, Grino M, Oliver C.

J Am Geriatr Soc. 2014 Sep;62(9):1759-63. doi: 10.1111/jgs.12968. Epub 2014 Aug 12.

PMID:
25113865
5.

Safety trial of high-intensity focused ultrasound therapy for pancreatic cancer.

Sofuni A, Moriyasu F, Sano T, Itokawa F, Tsuchiya T, Kurihara T, Ishii K, Tsuji S, Ikeuchi N, Tanaka R, Umeda J, Tonozuka R, Honjo M, Mukai S, Fujita M, Itoi T.

World J Gastroenterol. 2014 Jul 28;20(28):9570-7. doi: 10.3748/wjg.v20.i28.9570.

6.

11C-methionine PET/CT imaging of 99mTc-MIBI-SPECT/CT-negative patients with primary hyperparathyroidism and previous neck surgery.

Traub-Weidinger T, Mayerhoefer ME, Koperek O, Mitterhauser M, Duan H, Karanikas G, Niederle B, Hoffmann M.

J Clin Endocrinol Metab. 2014 Nov;99(11):4199-205. doi: 10.1210/jc.2014-1267. Epub 2014 Jul 16.

PMID:
25029418
7.

US-guided high-intensity focused ultrasound as a promising non-invasive method for treatment of primary hyperparathyroidism.

Kovatcheva R, Vlahov J, Stoinov J, Lacoste F, Ortuno C, Zaletel K.

Eur Radiol. 2014 Sep;24(9):2052-8. doi: 10.1007/s00330-014-3252-4. Epub 2014 Jun 4.

PMID:
24895038
8.

Pilot study of high-intensity focused ultrasound ablation as a bridging therapy for hepatocellular carcinoma patients wait-listed for liver transplantation.

Chok KS, Cheung TT, Lo RC, Chu FS, Tsang SH, Chan AC, Sharr WW, Fung JY, Dai WC, Chan SC, Fan ST, Lo CM.

Liver Transpl. 2014 Aug;20(8):912-21. doi: 10.1002/lt.23892. Epub 2014 Jun 24.

PMID:
24753206
9.

Transoral parathyroid surgery--a new alternative or nonsense?

Karakas E, Steinfeldt T, Gockel A, Mangalo A, Sesterhenn A, Bartsch DK.

Langenbecks Arch Surg. 2014 Aug;399(6):741-5. doi: 10.1007/s00423-014-1187-5. Epub 2014 Apr 13.

PMID:
24728604
10.

Bilateral neck exploration in patients with primary hyperparathyroidism and discordant imaging results: a single-centre study.

Philippon M, Guerin C, Taieb D, Vaillant J, Morange I, Brue T, Conte-Devolx B, Henry JF, Slotema E, Sebag F, Castinetti F.

Eur J Endocrinol. 2014 Apr 10;170(5):719-25. doi: 10.1530/EJE-13-0796. Print 2014 May.

11.

Correlation between ultrasound reflection intensity and tumor ablation ratio of late-stage pancreatic carcinoma in HIFU therapy: dynamic observation on ultrasound reflection intensity.

Ge HY, Miao LY, Wang JR, Xiong LL, Yan F, Zheng CS, Jia JW, Cui LG, Chen W.

ScientificWorldJournal. 2013 Dec 26;2013:852874. doi: 10.1155/2013/852874. eCollection 2013.

12.

Survival analysis of high-intensity focused ultrasound therapy vs. transarterial chemoembolization for unresectable hepatocellular carcinomas.

Cheung TT, Poon RT, Jenkins CR, Chu FS, Chok KS, Chan AC, Tsang SH, Dai WC, Yau TC, Chan SC, Fan ST, Lo CM.

Liver Int. 2014 Jul;34(6):e136-43. doi: 10.1111/liv.12474. Epub 2014 Feb 14.

PMID:
24451026
13.

Impact of cinacalcet hydrochloride in clinical management of primary hyperparathyroidism in multiple endocrine neoplasia type 1.

Del Prete M, Marotta V, Ramundo V, Marciello F, Di Sarno A, Esposito R, Carratù AC, De Luca Di Roseto C, Di Somma C, Colao A, Faggiano A.

Minerva Endocrinol. 2013 Dec;38(4):389-94.

PMID:
24285106
14.

High intensity focused ultrasound treatment for patients with local advanced pancreatic cancer.

Gao HF, Wang K, Meng ZQ, Chen Z, Lin JH, Zhou ZH, Wang P, Shi WD, Sheng YH.

Hepatogastroenterology. 2013 Nov-Dec;60(128):1906-10.

PMID:
24088318
15.

Multigland disease and slower decline in intraoperative PTH characterize mild primary hyperparathyroidism.

Schneider DF, Burke JF, Ojomo KA, Clark N, Mazeh H, Sippel RS, Chen H.

Ann Surg Oncol. 2013 Dec;20(13):4205-11. doi: 10.1245/s10434-013-3190-4. Epub 2013 Aug 14.

16.

Minimal benefit to subsequent intraoperative parathyroid hormone testing after all four glands have been identified.

Ahmed K, Alhefdhi A, Schneider DF, Ojomo KA, Sippel RS, Chen H, Mazeh H.

Ann Surg Oncol. 2013 Dec;20(13):4200-4. doi: 10.1245/s10434-013-3188-y. Epub 2013 Aug 14.

PMID:
23943032
17.
18.

Can the use of intraoperative intact parathyroid hormone monitoring be abandoned in patients with hyperparathyroidism?

Sakimura C, Minami S, Hayashida N, Uga T, Inokuchi N, Eguchi S.

Am J Surg. 2013 Oct;206(4):574-7. doi: 10.1016/j.amjsurg.2013.01.043. Epub 2013 Jul 2.

PMID:
23827512
19.

Mid-term clinical efficacy of a volumetric magnetic resonance-guided high-intensity focused ultrasound technique for treatment of symptomatic uterine fibroids.

Ikink ME, Voogt MJ, Verkooijen HM, Lohle PN, Schweitzer KJ, Franx A, Mali WP, Bartels LW, van den Bosch MA.

Eur Radiol. 2013 Nov;23(11):3054-61. doi: 10.1007/s00330-013-2915-x. Epub 2013 Jun 21.

PMID:
23793518
20.

High-intensity focused ultrasound ablation: an effective bridging therapy for hepatocellular carcinoma patients.

Cheung TT, Fan ST, Chan SC, Chok KS, Chu FS, Jenkins CR, Lo RC, Fung JY, Chan AC, Sharr WW, Tsang SH, Dai WC, Poon RT, Lo CM.

World J Gastroenterol. 2013 May 28;19(20):3083-9. doi: 10.3748/wjg.v19.i20.3083.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk